Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
London
SEC filing record 1 source field available
Fiscal year end
31 December
Mereo BioPharma Group plc has filed 433 SEC EDGAR filings since 01 Dec 2017

SEC filing history

Showing 1-25 of 123 matching filings.

Per page
25
Current page
1
6-K File 001-38452

6-K

Filing date
18 Dec 2023
Reporting date
18 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
29 Nov 2023
Reporting date
29 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
16 Nov 2023
Reporting date
16 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
23 Oct 2023
Reporting date
23 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
17 Oct 2023
Reporting date
17 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
20 Sep 2023
Reporting date
20 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
06 Jul 2023
Reporting date
06 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
30 Jun 2023
Reporting date
30 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
07 Jun 2023
Reporting date
07 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
05 Jun 2023
Reporting date
05 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
22 May 2023
Reporting date
22 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
08 May 2023
Reporting date
08 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
05 May 2023
Reporting date
05 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
27 Apr 2023
Reporting date
27 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
12 Apr 2023
Reporting date
12 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
28 Mar 2023
Reporting date
28 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
21 Mar 2023
Reporting date
21 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
10 Nov 2022
Reporting date
10 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
10 Nov 2022
Reporting date
10 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
02 Nov 2022
Reporting date
02 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
28 Oct 2022
Reporting date
28 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
21 Oct 2022
Reporting date
21 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
18 Oct 2022
Reporting date
18 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .